A tailored course, built for your situation
Implementation-Focused AI in Pharmaceutical R&D Operations for Regulated Industries
Master compliant, scalable AI integration in drug development and regulatory workflows
The situation this course is for
Teams adopt AI tools too quickly without aligning to quality systems, leading to rework, delayed submissions, and failed inspections. The gap isn't technical skill, it's knowing how to operationalize AI within validated environments.
Who this is for
Regulatory affairs leads, quality assurance managers, clinical operations directors, and data science leads in biopharma who need to deploy AI responsibly without compromising compliance.
Who this is not for
This is not for academic researchers focused solely on AI theory, nor for professionals outside regulated life sciences sectors.
What you walk away with
- Apply AI validation frameworks aligned with FDA and EMA expectations
- Design audit-ready AI documentation packages
- Integrate machine learning models into GxP-compliant workflows
- Manage change control and versioning for AI-driven processes
- Lead cross-functional AI implementation teams with confidence
The 12 modules (with all 144 chapters)
- Defining AI in the context of drug discovery
- Regulatory landscape: FDA, EMA, and ICH guidelines
- Distinguishing AI from traditional software validation
- Risk-based classification of AI applications
- Quality by design in AI development
- Role of ALCOA+ in AI-generated data
- Ethical considerations in clinical AI
- Data provenance and lineage tracking
- Stakeholder alignment: QA, IT, R&D
- Building a compliance-aware AI culture
- Documentation standards for AI projects
- Case study: AI in preclinical screening
- Establishing an AI review board
- Tiered approval processes for AI models
- Integration with existing quality management systems
- Model inventory and registry design
- Change control workflows for AI updates
- Versioning strategies for AI pipelines
- Audit trail requirements for AI decisions
- Periodic review cycles for deployed models
- Delegation of authority in AI operations
- Training and competency tracking
- Vendor oversight for third-party AI tools
- Case study: Governance in a global pharma
- Data lifecycle management for AI
- Source data verification in AI training sets
- Handling missing or anomalous data
- Data anonymization and privacy compliance
- Metadata standards for AI inputs
- Data lineage mapping techniques
- Storage and retention policies
- Access controls for AI datasets
- Data refresh and retraining triggers
- Handling external data sources
- Data quality dashboards
- Case study: Real-world data in regulatory submissions
- Defining model purpose and scope
- Selection of appropriate algorithms
- Training data representativeness
- Bias detection and mitigation
- Model interpretability techniques
- Validation study design
- Performance metrics for regulatory contexts
- Prospective vs retrospective validation
- Model drift detection
- Revalidation triggers
- Documentation templates
- Case study: Validating a toxicity prediction model
- Understanding GxP system boundaries
- API design for regulated environments
- Data flow mapping for AI integrations
- Validation of integration points
- Error handling and recovery procedures
- Monitoring AI outputs in production
- Alerting on model degradation
- Disaster recovery planning
- Change management for integrated AI
- User access and role-based controls
- Audit trail integration
- Case study: AI in clinical trial monitoring
- Defining AI model lifecycle phases
- Change control documentation
- Impact assessment for model updates
- Approval workflows for AI changes
- Rollback procedures
- Version control for AI models
- Model retirement planning
- Knowledge transfer for AI systems
- Post-deployment review processes
- Handling emergency changes
- Regulatory reporting of AI changes
- Case study: Updating a pharmacovigilance model
- Common inspection findings in AI
- Document organization for audits
- Model validation evidence packages
- Data integrity readiness
- Staff interview preparation
- Mock audit exercises
- Response protocols for audit findings
- Corrective action planning
- Pre-submission meetings with regulators
- Post-inspection follow-up
- Continuous improvement cycles
- Case study: FDA inspection of an AI-driven CMC process
- Stakeholder identification and engagement
- Communication strategies for technical and non-technical teams
- Project management frameworks for AI
- Resource allocation for AI projects
- Risk management in AI deployments
- Escalation pathways for issues
- Performance metrics for AI teams
- Conflict resolution in cross-functional settings
- Vendor management for AI services
- Training and upskilling plans
- Succession planning for AI roles
- Case study: Launching an enterprise AI program
- When to disclose AI use in submissions
- Module 3.2.S requirements for AI
- Module 5.3 requirements for AI
- Clinical study reports with AI components
- Transparency expectations for algorithms
- Validation evidence in submission packages
- Reference to guidance documents
- Handling proprietary algorithms
- Post-approval change management
- Interactions with CMC reviewers
- Global submission differences
- Case study: AI in a BLA submission
- Bias in training data and model outputs
- Fairness in clinical decision support
- Transparency vs. proprietary interests
- Patient consent for AI use
- Explainability in clinical contexts
- Accountability for AI-driven decisions
- Public trust in AI-assisted medicine
- Equity in access to AI-enhanced therapies
- Whistleblower protections
- Corporate social responsibility
- Stakeholder engagement on AI ethics
- Case study: AI in rare disease diagnosis
- Assessing organizational readiness
- Pilot project selection
- Center of excellence models
- Standardization of AI practices
- Knowledge sharing mechanisms
- Performance benchmarking
- Cost-benefit analysis of AI
- ROI measurement for AI projects
- Change management for AI adoption
- Leadership sponsorship models
- Global harmonization of AI policies
- Case study: Scaling AI in a multinational
- Monitoring regulatory trends
- Adapting to new guidance
- Technology watch for AI
- Skills development for AI teams
- Strategic partnerships for AI
- Investment planning for AI
- Scenario planning for AI disruption
- Succession planning for AI leadership
- Continuous improvement frameworks
- Innovation pipelines for AI
- Long-term data strategy
- Case study: Preparing for next-gen AI in drug discovery
How this maps to your situation
- New AI initiatives in regulated environments
- Post-inspection remediation of AI systems
- Scaling pilot AI projects enterprise-wide
- Preparing for regulatory submissions with AI components
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 36 hours total, designed for self-paced learning with practical application exercises.
How this compares to the alternatives
Unlike generic AI courses, this program is tailored to pharmaceutical R&D in regulated environments, offering implementation-grade detail not found in academic or broad-market offerings.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.